UBS Group »

Revolution Medicines shares owned by UBS Group

Quarter-by-quarter ownership of Revolution Medicines (RVMDW) shares owned by UBS Group from 13F filings

Historical chart of UBS Group investment in Revolution Medicines

Tip: Access up to 7 years of quarterly data

All positions including Revolution Medicines held by UBS Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Revolution Medicines by UBS Group

Quarter filed Position value Share count Share price at filing
2023-12-31 $320 971 0.33

More positions owned by UBS Group

Microsoft Corporation (MSFT)
Apple Call Option (AAPL)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Ishares Tr Russell 2000 Etf (IWM)
Amazon Call Option (AMZN)
NVIDIA Corporation (NVDA)
Ubs Group SHS (UBS)
Broadcom (AVGO)
JPMorgan Chase & Co. (JPM)
Alphabet Cap Stk Cl A (GOOGL)
Ishares Tr 20 Yr Tr Bd Etf (TLT)
Union Pacific Corporation (UNP)
Alphabet Cap Stk Cl C Put Option (GOOG)
Meta Platforms Cl A (META)

View all positions for UBS Group

Top funds holding Revolution Medicines

D. E. Shaw & Co
T. Rowe Price Associates
Walleye Trading Advisors
Marshall Wace
Perceptive Advisors
Bleichroeder
Cowen And Company
OZ Management
Davidson Kempner Capital Management
Millennium Management
DLK Investment Management
Weiss Asset Management LP[1
Wolverine Asset Management
TD Asset Management
CSS

View all funds holding Revolution Medicines